medical-innovation
2 cases — ← All topics
| Case | Title | Lower Court | Docketed | Status | Flags | Tags | Question Presented |
|---|---|---|---|---|---|---|---|
| 24-1187 | Vanda Pharmaceuticals, Inc. v. Food and Drug Administration, et al. | District of Columbia | 2025-05-21 | Denied | Response RequestedResponse WaivedRelisted (2) | administrative-law agency-discretion drug-approval fda-regulation medical-innovation statutory-interpretation | Congress enacted the Fast Track program to speed the development and approval of certain novel therapies. It required FDA to designate "a new drug" as… |
| 19-430 | Athena Diagnostics, Inc., et al. v. Mayo Collaborative Services, LLC, dba Mayo Medical Laboratories, et al. | Federal Circuit | 2019-10-02 | Denied | Amici (11) | 35-usc-101 chemical-process chemical-steps diagnostic-method federal-circuit medical-diagnostics medical-innovation molecular-detection novel-molecules patent-eligibility patent-protection precedent subject-matter-eligibility | Whether a new and specific method of diagnosing a medical condition is patent-eligible subject matter, where the method detects a molecule never previ… |